Proteomic profiling of 13 paired ductal infiltrating breast carcinomas and non‐tumoral adjacent counterparts
暂无分享,去创建一个
Patrizia Cancemi | Ida Pucci‐Minafra | Maria Rita Marabeti | Nadia Ninfa Albanese | Gianluca Di Cara | Pietra Taormina | Antonio Marrazzo | I. Pucci‐Minafra | P. Cancemi | A. Marrazzo | N. Albanese | G. Di Cara | M. Marabeti | P. Taormina
[1] Otto Warburn,et al. THE METABOLISM OF TUMORS , 1931 .
[2] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[3] H. Jörnvall,et al. Analysis of polypeptide expression in benign and malignant human breast lesions , 1997, Electrophoresis.
[4] W. Donegan. Tumor‐related prognostic factors for breast cancer , 1997, CA: a cancer journal for clinicians.
[5] M A Sirover,et al. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. , 1999, Biochimica et biophysica acta.
[6] H. Rochefort,et al. Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. , 2000, Clinica chimica acta; international journal of clinical chemistry.
[7] M. V. van Hemert,et al. 14‐3‐3 proteins: key regulators of cell division, signalling and apoptosis , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[8] P. Savagner,et al. Leaving the neighborhood: molecular mechanisms involved during epithelial‐mesenchymal transition , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[9] M. Maines,et al. Nuclear localization of biliverdin reductase in the rat kidney: response to nephrotoxins that induce heme oxygenase-1. , 2001, The Journal of pharmacology and experimental therapeutics.
[10] A. Yu,et al. The association of 14-3-3gamma and actin plays a role in cell division and apoptosis in astrocytes. , 2002, Biochemical and biophysical research communications.
[11] M. Maines,et al. Human Biliverdin Reductase Is a Leucine Zipper-like DNA-binding Protein and Functions in Transcriptional Activation of Heme Oxygenase-1 by Oxidative Stress* , 2002, The Journal of Biological Chemistry.
[12] Simona Fontana,et al. Proteomic Patterns of Cultured Breast Cancer Cells and Epithelial Mammary Cells , 2002, Annals of the New York Academy of Sciences.
[13] A contribution to breast cancer cell proteomics: Detection of new sequences , 2002, Proteomics.
[14] Sang Won Kang,et al. Peroxiredoxins in breast carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] H. Hermeking. The 14-3-3 cancer connection , 2003, Nature Reviews Cancer.
[16] S. Shenolikar,et al. PP1 control of M phase entry exerted through 14‐3‐3‐regulated Cdc25 dephosphorylation , 2003, The EMBO journal.
[17] Clark S. Phillipson,et al. Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells. , 2004, Molecular biology of the cell.
[18] T. Isono,et al. Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, γ‐synuclein, and catechol‐o‐methyltransferase) identified by proteomic analysis , 2004, Cancer science.
[19] M. Maines,et al. Biliverdin Reductase, a Novel Regulator for Induction of Activating Transcription Factor-2 and Heme Oxygenase-1* , 2004, Journal of Biological Chemistry.
[20] Sui Huang,et al. Components of U3 snoRNA-containing complexes shuttle between nuclei and the cytoplasm and differentially localize in nucleoli: implications for assembly and function. , 2003, Molecular biology of the cell.
[21] D. Lodygin,et al. The role of epigenetic inactivation of 14-3-3σ in human cancer , 2005, Cell Research.
[22] Richard A. Miller,et al. The thioredoxin reductase/thioredoxin system: Novel redox targets for cancer therapy , 2005, Cancer biology & therapy.
[23] Stephen Russell,et al. Proteomics of breast carcinoma. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[24] D. Nowak,et al. Beta-actin in human colon adenocarcinoma cell lines with different metastatic potential. , 2005, Acta biochimica Polonica.
[25] E. Keller,et al. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein , 2005, Journal of cellular biochemistry.
[26] Y. Li,et al. Identification and analysis of tumour-associated antigens in hepatocellular carcinoma , 2005, British Journal of Cancer.
[27] M. Maines,et al. Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[28] Qing‐Yu He,et al. Comparative proteomic analysis of esophageal squamous cell carcinoma , 2005, Proteomics.
[29] Chao Xu,et al. NMR structure and regulated expression in APL cell of human SH3BGRL3 , 2005, FEBS letters.
[30] S. Larson,et al. 18F-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Scanning Affects Surgical Management in Selected Patients With High-Risk, Operable Breast Carcinoma , 2006, Annals of Surgical Oncology.
[31] E. Dees,et al. Targeting the ubiquitin-proteasome pathway in breast cancer therapy. , 2006, Future oncology.
[32] M. Becchi,et al. Expanding the protein catalogue in the proteome reference map of human breast cancer cells , 2006, Proteomics.
[33] Susumu Goto,et al. Effects of post-electrophoretic analysis on variance in gel-based proteomics , 2006, Expert review of proteomics.
[34] Yusuke Nakamura,et al. Overexpression of Peptidyl-Prolyl Isomerase-Like 1 Is Associated with the Growth of Colon Cancer Cells , 2006, Clinical Cancer Research.
[35] D. Nandi,et al. The ubiquitin-proteasome system , 2006, Journal of Biosciences.